Literature DB >> 12106510

Performance and use of HSV type-specific serology test kits.

Rhoda L Ashley1.   

Abstract

Herpes simplex virus type-specific serology tests based on glycoprotein gG-1 and/or gG-2 are important diagnostic tools to establish aetiology of genital symptoms and identify patients with unrecognized genital herpes. Clinicians can now select from three very different Food and Drug Administration-licensed kits. Diagnology's POCkittrade mark HSV-2 is a point of care test for herpes simplex virus type 2 (HSV-2) antibodies. Clinicians can perform this test while the patient waits. Focus Technologies' HerpeSelect enzymelinked immunosorbent assays (ELISAs) for herpes simplex virus type 1 (HSV-1) and HSV-2 are more traditional tests that can be semiautomated for high throughput at low cost in laboratories. Focus Technologies' HerpeSelect Immunoblot is a novel strip immunoblot that can be used for low volume testing in laboratories or even by healthcare facilities that are accredited for moderately complex testing. This review summarizes the performance data of these tests and describes how to interpret their results. Finally, situations that warrant follow-up testing are described along with suggested strategies for such testing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106510

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  35 in total

1.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Sero-prevalence of herpes simplex type 2 virus (HSV-2) and HIV infection in Kampala, Uganda.

Authors:  Edith Nakku-Joloba; Fred Kambugu; Julius Wasubire; Joshua Kimeze; Robert Salata; Jeffrey M Albert; Alfred Rimm; Christopher Whalen
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

3.  Genital herpes.

Authors:  A M Geretti
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

4.  Should sexually transmitted disease clinics routinely offer serologic testing for genital herpes?

Authors:  Michael F Rein
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

5.  Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.

Authors:  J Lingappa; E Nakku-Joloba; A Magaret; D Friedrich; J Dragavon; F Kambugu; M Joloba; C Whalen; R Coombs; C Celum; R Ashley Morrow
Journal:  Int J STD AIDS       Date:  2010-09       Impact factor: 1.359

6.  Performance of HSV-2 type specific serological tests in men in Kenya.

Authors:  Musa Otieno Ng'ayo; David Friedrich; King K Holmes; Elizabeth Bukusi; Rhoda Ashley Morrow
Journal:  J Virol Methods       Date:  2009-10-23       Impact factor: 2.014

7.  Herpes simplex virus genital infections: current concepts.

Authors:  Carolyn Gardella
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

8.  Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.

Authors:  M J Binnicker; D J Jespersen; J A Harring
Journal:  Clin Vaccine Immunol       Date:  2009-12-09

9.  Serologic screening for herpes simplex virus type 2 in persons with human immunodeficiency virus.

Authors:  Nicholas J Van Wagoner; Rhoda Morrow; Jeannette Lee; Paula Dixon; Edward W Hook
Journal:  Am J Med Sci       Date:  2013-08       Impact factor: 2.378

10.  Seroprevalence and factors associated with herpes simplex virus type 2 among HIV-negative high-risk men who have sex with men from Rio de Janeiro, Brazil: a cross-sectional study.

Authors:  Junia Rodrigues; Beatriz Grinsztejn; Francisco I Bastos; Luciane Velasque; Paula M Luz; Claudia T V de Souza; Ingebourg Georg; Jose H Pilotto; Valdilea G Veloso
Journal:  BMC Infect Dis       Date:  2009-04-01       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.